Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20231676 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
Condition: Recurrent Glioblastoma Multiforme
Interventions: Radiation: Stereotactic hypofractionated RT 5x5Gy;   Radiation: Stereotactic hypofractionated RT 5x7Gy
2 Terminated
Has Results
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
Condition: Brain Cancer
Interventions: Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Lithium Carbonate;   Radiation: Radiation

Indicates status has not been verified in more than two years